Categories: Entertainment

Vantage Celebrates Dual Wins at the Finance Magnates Awards 2025 in Vietnam and the UK

PORT VILA, Vanuatu , Nov. 28, 2025 /PRNewswire/ — Vantage celebrates a double win at the Finance Magnates Awards 2025, taking home Fastest Growing Broker 2025 in Vietnam and Best Affiliate Program Broker 2025 in the UK. These awards were presented to the Vantage brand as part of the event’s regional and national award categories.

- Advertisement -

The Finance Magnates Awards remain one of the industry’s most respected benchmarks, determined through community voting and expert evaluation. Vantage’s recognition highlights the brand’s ongoing initiatives across its operations, supported by enhanced education resources and tools for both new and experienced traders. The Best Affiliate Program Broker award underscores the strength of Vantage’s partner ecosystem, built on transparent tracking, competitive commissions, and dedicated client support.

- Advertisement -

“Our wins in Vietnam and the UK celebrates our team’s dedication and our clients’ trust — both of which drive our continued success,” said Marc Despallieres, CEO of Vantage. “These accolades validate our efforts to understand client needs and elevate the trading experience across all markets.”

- Advertisement -

Together, these awards reflect Vantage’s strategy to enhance client experience, strengthen capabilities, and deliver innovation-driven trading solutions.

- Advertisement -

For more information about Vantage and its award-winning services, visit Vantage’s website. Service availability varies by jurisdiction and entity.

- Advertisement -

About Vantage
Vantage Markets (or Vantage) is a multi-asset CFD broker offering clients access to a nimble and powerful service for trading Contracts for Difference (CFDs) products, including Forex, Commodities, Indices, Shares, ETFs, and Bonds.

- Advertisement -

With 16 years of market experience, Vantage goes beyond the role of broker, providing a reliable trading platform that provides clients access to trading opportunities.

- Advertisement -

trade smarter @vantage
RISK WARNING: CFDs are complex instruments and carry a high risk of losing money rapidly due to leverage. Ensure you understand the risks before trading.

- Advertisement -

Disclaimer: This article is provided for informational purposes only and does not constitute financial advice, an offer, or solicitation of any financial products or services. The content is not intended for residents of any jurisdiction where such distribution or use would be contrary to local law or regulation. The awards described are brand-level recognitions and do not indicate the licensing permissions of any specific Vantage entity. Readers are advised to seek independent professional advice before making any investment or financial decisions. Any reliance you place on the information presented is strictly at your own risk.

- Advertisement -

Photo – https://mma.prnewswire.com/media/2834084/Vantage_Celebrates_Dual_Wins_Finance_Magnates_Awards_2025_Vietnam_UK.jpg
Logo – https://mma.prnewswire.com/media/1745281/Vantage_Logo.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/vantage-celebrates-dual-wins-at-the-finance-magnates-awards-2025-in-vietnam-and-the-uk-302627997.html

- Advertisement -
PRNW Agency

Recent Posts

Novartis Vanrafia Phase III data support slowing of kidney function decline in patients with IgA nephropathy

Basel, February 13, 2026 – Novartis today announced final results from the Phase III ALIGN…

4 days ago

January Commercial Chapter 11 Filings Increase 76% Over 2025

NEW YORK, Feb. 06, 2026 (GLOBE NEWSWIRE) -- There were 956 commercial Chapter 11 filings…

1 week ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

Basel, February 6, 2026 – Novartis today broke ground on a new, state-of-the-art global Biomedical…

2 weeks ago

Novartis ianalumab receives FDA Breakthrough Therapy designation for Sjgrens disease

Basel, January 16, 2026 – Novartis today announced that the US Food and Drug Administration (FDA)…

1 month ago

Personar Appoints Former Genius Sports COO Eric Stevens as Chief Operating Officer to Scale Award-Winning Sports Technology Platform

Tuesday 13 January, 2026 LONDON – Tuesday, January 13, 2026 – Personar, the AI sports…

1 month ago

Novartis to add radioligand therapy manufacturing facility in Winter Park, Florida, fourth in US to serve patients and advance $23 billion investment

Basel, January 9, 2026 – Novartis, a leading global innovative medicines company, today announced plans…

1 month ago